ZONISAMIDE
- Product NDC
- 63629-5008
- 11-digit product format
- 636295008
- Labeler code
- 63629
- Product ID
- 63629-5008_5ff7324f-e0aa-44fe-8f3f-016983c4f4f0
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ZONISAMIDE
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA077636
- Marketing category
- ANDA
- Marketing start
- 2006-07-27
- Marketing end
- 0000-00-00
- Substance
- ZONISAMIDE
- Active strength
- 50 mg/1
- Pharmacologic classes
- Decreased Central Nervous System Disorganized Electrical Activity [PE],Anti-epileptic Agent [EPC],Sulfonamides [CS],Carbonic Anhydrase Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA]
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 63629-5008-1 | 2023-03-07 | C162847 | 48780-1 | 9855e2a2-47a3-60a7-e053-dbdaa90a05bd | f47f15fd-43b3-4599-9550-8efdfe36b689 |
| 63629-5008-2 | 2023-03-07 | C162847 | 48780-1 | 9855e2a2-47a3-60a7-e053-dbdaa90a05bd | f47f15fd-43b3-4599-9550-8efdfe36b689 |
| 63629-5008-3 | 2023-03-07 | C162847 | 48780-1 | 9855e2a2-47a3-60a7-e053-dbdaa90a05bd | f47f15fd-43b3-4599-9550-8efdfe36b689 |
| 63629-5008-4 | 2023-03-07 | C162847 | 48780-1 | 9855e2a2-47a3-60a7-e053-dbdaa90a05bd | f47f15fd-43b3-4599-9550-8efdfe36b689 |
| 63629-5008-1 | 2019-11-27 | C162847 | 48780-1 | 9855e2a2-47a3-60a7-e053-dbdaa90a05bd | f47f15fd-43b3-4599-9550-8efdfe36b689 |
| 63629-5008-2 | 2019-11-27 | C162847 | 48780-1 | 9855e2a2-47a3-60a7-e053-dbdaa90a05bd | f47f15fd-43b3-4599-9550-8efdfe36b689 |
| 63629-5008-3 | 2019-11-27 | C162847 | 48780-1 | 9855e2a2-47a3-60a7-e053-dbdaa90a05bd | f47f15fd-43b3-4599-9550-8efdfe36b689 |
| 63629-5008-4 | 2019-11-27 | C162847 | 48780-1 | 9855e2a2-47a3-60a7-e053-dbdaa90a05bd | f47f15fd-43b3-4599-9550-8efdfe36b689 |